Stocks
Intelligent OutlookNVS-
Intelligent Outlook
NVS-
Prev Close-
50D MA-
200D MA-
52W High-
Live Price
NVS 24H Rolling
0.000.00%0.00
Rolling: Last 24h | 5m
NVS
Asset Information
Company Profile
Company:NVS
Sector:Pharmaceuticals
Industry:Pharmaceuticals
Country:CH
Employees:75,883
IPO Date:1996-11-07
Website:www.novartis.com/
Technicals & Growth
Market Cap:$242.36B
Shares O/S:1,956,749,582
52W High:$133.55
52W Low:$96.06
50D MA:$127.38
200D MA:$116.39
Financial Ratios
P/E Ratio:16.92
EPS:$7.32
Profit Margin:24.67%
ROE (TTM):30.00%
ROA (TTM):12.59%
Div. Per Share:$3.99
NVS
Novartis develops and manufactures innovative drugs. Key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.
Loading chart library...
Financial Data (Macrotrends)
Historical Data
Loading...